Cancer of the Endometrium
7
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer
Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer
Scale Down for Endometrial Cancer
Endometrial Cancer and Array CGH
A Trial for Patients With Advanced/Recurrent Endometrial Cancer